These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 15732041
1. [Functional loss of the transplanted kidney: immunological and non-immunological factors]. Cattaneo D, Perico N, Remuzzi G. G Ital Nefrol; 2004; 21 Suppl 26():S28-33. PubMed ID: 15732041 [Abstract] [Full Text] [Related]
2. The renin-angiotensin system: an old, newly discovered player in immunoregulation. Geara AS, Azzi J, Jurewicz M, Abdi R. Transplant Rev (Orlando); 2009 Jul; 23(3):151-8. PubMed ID: 19539879 [Abstract] [Full Text] [Related]
3. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB. Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959 [Abstract] [Full Text] [Related]
4. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L. Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [Abstract] [Full Text] [Related]
5. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model. Koch M, Broecker V, Heratizadeh A, Doege C, Strehlau J, Mengel M, Nashan B. Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711 [Abstract] [Full Text] [Related]
6. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection. Pescovitz MD. Clin Transplant; 2006 Jul; 20(1):48-54. PubMed ID: 16556153 [Abstract] [Full Text] [Related]
7. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Akl A, Jones ND, Rogers N, Bakr MA, Mostafa A, El Shehawy el M, Ghoneim MA, Wood KJ. Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959 [Abstract] [Full Text] [Related]
8. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts. Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K. Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275 [Abstract] [Full Text] [Related]
9. Restorative and rejection-associated lymphangiogenesis after renal transplantation: friend or foe? Vass DG, Hughes J, Marson LP. Transplantation; 2009 Dec 15; 88(11):1237-9. PubMed ID: 19996921 [Abstract] [Full Text] [Related]
10. The renin angiotensin system blockade in kidney transplantation: pros and cons. Cruzado JM, Rico J, Grinyó JM. Transpl Int; 2008 Apr 15; 21(4):304-13. PubMed ID: 18266774 [Abstract] [Full Text] [Related]
11. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Braudeau C, Ashton-Chess J, Giral M, Dugast E, Louis S, Pallier A, Braud C, Moreau A, Renaudin K, Soulillou JP, Brouard S. Transplantation; 2008 Jul 15; 86(1):130-6. PubMed ID: 18622290 [Abstract] [Full Text] [Related]
12. Protective effects of atorvastatin on chronic allograft nephropathy in rats. Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M. J Surg Res; 2007 Dec 15; 143(2):428-36. PubMed ID: 17628598 [Abstract] [Full Text] [Related]
13. [Impact of some immunological and non-immunological factors on early and distant function of transplanted kidney]. Sierńko J. Ann Acad Med Stetin; 2004 Dec 15; 50(1):53-67. PubMed ID: 16871744 [Abstract] [Full Text] [Related]
14. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Jennings DL, Taber DJ. Ann Pharmacother; 2008 Jan 15; 42(1):116-20. PubMed ID: 18094340 [Abstract] [Full Text] [Related]
15. Sotrastaurin, a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis. Manicassamy S. Curr Opin Investig Drugs; 2009 Nov 15; 10(11):1225-35. PubMed ID: 19876790 [Abstract] [Full Text] [Related]
16. Transplant glomerulopathy: morphology, associations and mechanism. Fotheringham J, Angel CA, McKane W. Nephron Clin Pract; 2009 Nov 15; 113(1):c1-7; discussion c7. PubMed ID: 19590229 [Abstract] [Full Text] [Related]
17. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T. Nephrology (Carlton); 2008 Feb 15; 13(1):80-6. PubMed ID: 18199109 [Abstract] [Full Text] [Related]
18. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients? Cheung CY, Liu YL, Wong KM, Chan HW, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Shek CC, Li CS. Nephrology (Carlton); 2008 Jun 15; 13(3):251-5. PubMed ID: 18221256 [Abstract] [Full Text] [Related]